Benefits and Safety of Tirofiban Among Acute Coronary Syndrome Patients With Mild to Moderate Renal Insufficiency
Open Access
- 21 May 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (20) , 2361-2366
- https://doi.org/10.1161/01.cir.0000016359.94919.16
Abstract
Background— The role of glycoprotein IIb/IIIa receptor antagonists for the treatment of patients with acute coronary syndrome and renal insufficiency remains undefined.Keywords
This publication has 20 references indexed in Scilit:
- Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIbJournal of the American College of Cardiology, 2001
- Determinants of mortality after myocardial infarction in patients with advanced renal dysfunctionAmerican Journal of Kidney Diseases, 2001
- Coronary Artery Bypass Grafting in 105 Patients with Hemodialysis-Dependent Renal FailureArtificial Organs, 2001
- Acute myocardial infarction in patients with end-stage renal diseaseKidney International, 1999
- Poor Long-Term Survival after Acute Myocardial Infarction among Patients on Long-Term DialysisNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptorsAmerican Journal of Kidney Diseases, 1996
- Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearanceCurrent Opinion in Nephrology and Hypertension, 1995
- Impaired high‐shear‐stress‐induced platelet aggregation in patients with chronic renal failure undergoing haemodialysisBritish Journal of Haematology, 1995
- Assessment of renal function and progression of diseaseCurrent Opinion in Nephrology and Hypertension, 1994